Calico Life Sciences Company
Biotechnology company focused on understanding the biology of aging and developing interventions for age-related diseases. Founded in 2013 as a subsidiary of Alphabet (Google’s parent), Calico combines deep biology research with advanced computational approaches. The company operates research facilities in the San Francisco Bay Area and runs extensive collaborations, including a landmark partnership with AbbVie, to translate discoveries into therapeutic pipelines targeting cancer, neurodegeneration, and metabolic disorders. Calico’s leadership includes Arthur Levinson, PhD (former Genentech CEO) and Hal Barron, MD as past R&D head. Its long-term mission is to extend the period of healthy human life by tackling the root mechanisms of aging. (calicolabs.com)
